Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

c-FOS Antikörper (Middle Region)

Dieses Anti-c-FOS-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von c-FOS in WB. Geeignet für Human. Dieses Primary Antibody wurde in 3+ Publikationen zitiert.
Produktnummer ABIN965712

Kurzübersicht für c-FOS Antikörper (Middle Region) (ABIN965712)

Target

Alle c-FOS (c-Fos) Antikörper anzeigen
c-FOS (c-Fos) (c-Fos)

Reaktivität

  • 179
  • 151
  • 136
  • 13
  • 12
  • 11
  • 8
  • 7
  • 6
  • 5
  • 4
  • 3
  • 3
  • 2
  • 1
Human

Wirt

  • 187
  • 22
  • 6
  • 1
  • 1
Kaninchen

Klonalität

  • 190
  • 24
  • 1
Polyklonal

Konjugat

  • 102
  • 9
  • 8
  • 7
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
Dieser c-FOS Antikörper ist unkonjugiert

Applikation

  • 179
  • 80
  • 80
  • 69
  • 36
  • 32
  • 32
  • 25
  • 17
  • 13
  • 9
  • 9
  • 6
  • 1
  • 1
  • 1
Western Blotting (WB)
  • Bindungsspezifität

    • 25
    • 23
    • 22
    • 18
    • 16
    • 15
    • 15
    • 9
    • 7
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Middle Region

    Kreuzreaktivität

    Maus, Ratte (Rattus)

    Kreuzreaktivität (Details)

    No cross reactivity with other proteins.

    Produktmerkmale

    Rabbit IgG polyclonal antibody for Proto-oncogene c-Fos (FOS) detection. Tested with WB in Human, Mouse, Rat.

    Immunogen

    A synthetic peptide corresponding to a sequence in the middle region of human C-FOS, identical to the related rat and mouse sequences.< br/>Immunogen was affinity purified.

    Isotyp

    IgG
  • Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 0.2 mL of distilled water will yield a concentration of 500 µg/mL.

    Buffer

    Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg Sodium azide.

    Konservierungsmittel

    Sodium azide, Thimerosal (Merthiolate)

    Handhabung

    Avoid repeated freezing and thawing.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    At -20 °C for one year. After reconstitution, at 4 °C for one month. It can also be aliquotted and stored frozen at -20 °C for a longer time.
  • Grigoriadis, Wang, Wagner: "Fos and bone cell development: lessons from a nuclear oncogene." in: Trends in genetics : TIG, Vol. 11, Issue 11, pp. 436-41, (1996) (PubMed).

    Saez, Rutberg, Mueller, Oppenheim, Smoluk, Yuspa, Spiegelman: "c-fos is required for malignant progression of skin tumors." in: Cell, Vol. 82, Issue 5, pp. 721-32, (1995) (PubMed).

    Barker, Rabin, Watson, Breg, Ruddle, Verma: "Human c-fos oncogene mapped within chromosomal region 14q21----q31." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 81, Issue 18, pp. 5826-30, (1984) (PubMed).

  • Target

    c-FOS (c-Fos) (c-Fos)

    Andere Bezeichnung

    Proto-oncogene c-Fos

    Hintergrund

    The human oncogene c-fos is cellular homolog of the transforming gene of Finkel-Biskis-Jinkins (FBJ) murine osteosarcoma virus which was mapped to a single human chromosome. c-Fos is encoded by the FOS gene. FOS was the first transcription factor identified that has a critical function in regulating the development of cells destined to form and maintain the skeleton. FOS is also a major component of the activator protein-1 (AP-1) transcription factor complex, which includes members of the JUN family. c-fos is a major nuclear target for signal transduction pathways involved in the regulation of cell growth, differentiation, and transformation. Using transgenic and knockout mice, Grigoriadis et al. (1995) established a unique role for the proto-oncogene and nuclear transcription factor, Fos, in regulating the differentiation and activity of specific bone cell populations, both during normal development and in bone disease.

    Pathways

    S100 Proteine
Sie sind hier:
Chat with us!